Jin Lu
About Jin Lu
Jin Lu is the Sr. Director of Global Product Quality at Bristol Myers Squibb, with over 15 years of experience in quality control and product quality management in the biopharmaceutical industry.
Current Role at Bristol Myers Squibb
Jin Lu is currently serving as the Sr. Director for Global Product Quality at Bristol Myers Squibb. In this role, Jin Lu is responsible for overseeing the quality control processes on a global scale, ensuring that all products meet stringent quality standards. This position demands extensive expertise in quality management, particularly in the biopharmaceutical industry.
Previous Experience at Novartis
Before rejoining Bristol Myers Squibb, Jin Lu worked at Novartis. From 2020 to 2021, Jin held the position of Product Quality Lead in Cell & Gene Therapy, TRD Quality in New Jersey. Prior to this, Jin served as AD, Global Product Quality Manager for Cell & Gene Therapy, NTO Quality from 2018 to 2020. These roles focused on maintaining product quality and compliance standards for innovative cell and gene therapy products.
Career at Eli Lilly and Company
Jin Lu's career at Eli Lilly and Company spanned over a decade. Between 2011 and 2018, Jin held various leadership roles including Associate Director QC Biochemistry, Manager of the QC Bioassay Group, and QC Supervisor. Jin initially joined ImClone Systems—a subsidiary of Eli Lilly—as a QC Scientist, moving up to QC Scientist II during a tenure from 2004 to 2011. These roles involved managing quality control for biochemistry and bioassay groups.
Educational Background
Jin Lu holds a Bachelor of Science degree from Nankai University and a Master of Science degree in Biochemistry from The Graduate Center at the City University of New York. This educational foundation has provided a strong basis for Jin's expertise in biopharmaceutical quality control and management.
Specialization in Cell and Gene Therapy
Jin Lu specializes in the quality management of cell and gene therapy products. This specialization includes ensuring compliance with industry standards and regulatory requirements during both the commercial and research and development phases. Jin's roles at Novartis and Eli Lilly underscore this specialization and illustrate a deep commitment to maintaining the highest standards of product quality.